文献速递泌尿生殖腹部MR

简化双参数MRI与标准多参数MRI诊断前列腺癌的比较:系统综述与Meta分析

Abbreviated Biparametric Versus Standard Multiparametric MRI for Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
PubMed 文献 · AJR Am J Roentgenol · 2018-12-04

该系统综述与Meta分析纳入10项研究、1705例患者和3419个病灶,比较简化双参数MRI(bpMRI)与标准多参数MRI(mpMRI)以前列腺穿刺活检或前列腺切除病理为参考标准诊断前列腺癌的效能。mpMRI敏感度0.79、特异度0.89,bpMRI敏感度0.79、特异度0.88,两者诊断效能无统计学显著差异,SROC曲线下面积分别为0.89和0.88(p=0.9944)。

要点

  • bpMRI与mpMRI诊断前列腺癌的敏感度均为0.79,特异度分别为0.88和0.89。
  • 两者SROC曲线下面积分别为0.89和0.88,差异无统计学意义(p=0.9944)。
  • 现有证据提示bpMRI与mpMRI诊断前列腺癌的效能相似。

核心结论

  • 现有证据表明,bpMRI与mpMRI诊断前列腺癌的效能相似。

研究设计与样本

  • 系统综述与Meta分析,纳入10项比较bpMRI与mpMRI诊断前列腺癌的原始研究,共1705例患者和3419个病灶,以引导穿刺活检或前列腺切除病理为参考标准,采用QUADAS-2工具评价方法学质量,用Stata 14计算诊断效能。

诊断标准与关键数值

  • mpMRI诊断前列腺癌:敏感度0.79(95%CI 0.69-0.87),特异度0.89(95%CI 0.70-0.96),阳性似然比6.9(95%CI 2.5-18.8),阴性似然比0.24(95%CI 0.16-0.35),诊断比值比29(95%CI 10-83)。
  • bpMRI诊断前列腺癌:敏感度0.79(95%CI 0.69-0.87),特异度0.88(95%CI 0.73-0.95),阳性似然比6.4(95%CI 2.9-14.5),阴性似然比0.24(95%CI 0.16-0.35),诊断比值比27(95%CI 11-67)。
  • SROC曲线下面积:mpMRI为0.89,bpMRI为0.88,两者差异无统计学意义(p=0.9944)。
  • 敏感性分析结果一致,bpMRI与mpMRI的SROC曲线下面积均为0.89(p=0.9349)。

临床应用与阅片要点

  • 作者结论认为,现有证据提示bpMRI与mpMRI诊断前列腺癌的效能相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The objective of our study was to evaluate the diagnostic accuracy of abbreviated biparametric MRI (bpMRI) versus standard multiparametric MRI (mpMRI) for prostate cancer (PCa) using guided biopsy or prostatectomy histopathology results as the reference standard.

MATERIALS AND METHODS: A comprehensive literature search of PubMed, Web of Science, and Cochrane Library databases was performed by two researchers independently and the relevant references were assessed. Original research studies comparing bpMRI with mpMRI in diagnosing PCa were included. The methodologic quality of eligible studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 tool. Data necessary to complete 2 × 2 contingency tables were obtained to calculate the diagnostic performance of bpMRI and mpMRI using Stata (version 14).

RESULTS: Ten studies were included, and a total of 1705 patients and 3419 lesions were analyzed. Sensitivity, specificity, positive likelihood ratio (LR), negative LR, and diagnostic odds ratio (DOR) of mpMRI in diagnosing PCa were 0.79 (95% CI, 0.69-0.87), 0.89 (95% CI, 0.70-0.96), 6.9 (95% CI, 2.5-18.8), 0.24 (95% CI, 0.16-0.35), and 29 (95% CI, 10-83). Sensitivity, specificity, positive LR, negative LR, and DOR of bpMRI in diagnosing PCa were 0.79 (95% CI, 0.69-0.87), 0.88 (95% CI, 0.73-0.95), 6.4 (95% CI, 2.9-14.5), 0.24 (95% CI, 0.16-0.35), and 27 (95% CI, 11-67). Meta-analysis showed no statistically significant difference between bpMRI and mpMRI for the diagnosis of PCa, and the areas under the summary ROC (SROC) curves were 0.89 and 0.88, respectively (p = 0.9944). Results of the sensitivity analysis were consistent, and the area under the SROC curve for bpMRI and mpMRI was 0.89 for both (p = 0.9349).

CONCLUSION: The available evidence indicates that bpMRI and mpMRI have similar diagnostic efficacy in diagnosing PCa.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Kang Z, Min X, Weinreb J, et al. Abbreviated Biparametric Versus Standard Multiparametric MRI for Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2018. PMID: 30512996. doi:10.2214/AJR.18.20103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。